Prevalence of WHO Transmitted Drug Resistance Mutations by Deep Sequencing in Antiretroviral-Naive Subjects in Hunan Province, China

被引:13
|
作者
Zou Xiaobai [1 ]
Xi, Chen [1 ]
Tian, Hongping [2 ]
Williams, Ann B. [3 ]
Wang, Honghong [4 ]
He, Jianmei [1 ]
Zhen, Jun [1 ]
Chiarella, Jennifer [5 ]
Blake, Lisebeth A. [6 ]
Turenchalk, Gregory [6 ]
Kozal, Michael J. [5 ]
机构
[1] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China
[2] Yale China Assoc, New Haven, CT USA
[3] UCLA Sch Nursing, Los Angeles, CA USA
[4] Cent S Univ, Changsha, Hunan, Peoples R China
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] 454 Life Sci, Branford, CT USA
来源
PLOS ONE | 2014年 / 9卷 / 06期
关键词
REVERSE-TRANSCRIPTASE INHIBITORS; MINORITY POPULATIONS; HIV-1; VARIANTS; THERAPY; FAILURE; GENOME;
D O I
10.1371/journal.pone.0098740
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. Objective: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naive subjects in Hunan Province by deep sequencing. Methods: ART-naive subjects diagnosed in Hunan between 2010-2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. Results: Deep sequencing was performed on samples from 90 ART-naive subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level >= 1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value >= 15). 17(19.5%) had PI TDRs at levels >1%. Conclusions: ART-naive subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV/AIDS patients during 1999-2012 in South Korea
    Park, Mina
    Kee, Mee-Kyung
    Rhee, JeeEun
    Park, Ji-Young
    Kim, Sung Soon
    Kang, Chun
    Choi, Ju-yeon
    JOURNAL OF CLINICAL VIROLOGY, 2016, 81 : 53 - 57
  • [42] Drug resistance mutations among HIV-1 strains from antiretroviral-naive patients in Martinique, French West Indies
    Césaire, R
    Dos Santos, G
    Abel, S
    Bera, O
    Sobesky, G
    Cabié, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (04) : 401 - 405
  • [43] High HIV-1 Diversity and Prevalence of Transmitted Drug Resistance Among Antiretroviral-Naive HIV-Infected Pregnant Women from Rio de Janeiro, Brazil
    Delatorre, Edson
    Silva-de-Jesus, Carlos
    Couto-Fernandez, Jose Carlos
    Pilotto, Jose H.
    Morgado, Mariza G.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (01) : 68 - 73
  • [44] HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naive individuals in Surabaya, Indonesia
    Kotaki, Tomohiro
    Khairunisa, Siti Qamariyah
    Witaningrum, Adiana Mutamsari
    Yunifiar, Muhammad Qushai M.
    Sukartiningrum, Septhia Dwi
    Diansyah, Muhammad Noor
    Rahayu, Retno Pudji
    Nasronudin
    Kameoka, Masanori
    AIDS RESEARCH AND THERAPY, 2015, 12
  • [45] Prevalence and clinical significance of transmitted drug-resistant (TDR) HIV mutations by ultra-deep sequencing (UDS) in HIV-infected ARV-naive subjects in CASTLE Study
    Lataillade, M.
    Chiarella, J.
    Yang, R.
    Schnittman, S.
    Wirtz, V.
    Mancini, M.
    Uy, J.
    Seekins, D.
    Krystal, M.
    McGrath, D.
    Simen, B.
    Egholm, M.
    Kozal, M.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A44 - A44
  • [46] Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection
    Hanna, GJ
    Balaguera, HU
    Freedberg, KA
    Werner, BG
    Craven, KAS
    Craven, DE
    D'Aquila, RT
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07): : 986 - 991
  • [47] Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
    Shuai Zhao
    Yi Feng
    Jing Hu
    Yang Li
    Zhongbao Zuo
    Jing Yan
    Jing Zhang
    Pi Cao
    Wei Xu
    Fan Li
    Yuxueyun Li
    Lingjie Liao
    Yuhua Ruan
    Yiming Shao
    Hui Xing
    Scientific Reports, 8
  • [48] Prevalence of HIV-1 drug resistance-associated mutations in a large cohort of antiretroviral-naive HIV-infected individuals in the USA from 2000-2009
    Ross, L. L.
    Wine, B.
    Horton, J. H.
    Vavro, C.
    St Clair, M.
    Ha, B. F.
    Pappa, K. A.
    Shaefer, M.
    ANTIVIRAL THERAPY, 2010, 15 : A50 - A50
  • [49] Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype CHIV-1
    Handema, R
    Terunuma, H
    Kasolo, F
    Kasai, H
    Sichone, M
    Yamashita, A
    Deng, XW
    Mulundu, G
    Ichiyama, K
    Munkanta, M
    Yokota, T
    Wakasugi, N
    Tezuka, F
    Yamamoto, N
    Ito, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (02) : 151 - 160
  • [50] National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011
    Descamps, Diane
    Assoumou, Lambert
    Chaix, Marie-Laure
    Chaillon, Antoine
    Pakianather, Sophie
    De Rougemont, Alexis
    Storto, Alexandre
    Dos Santos, Georges
    Krivine, Anne
    Delaugerre, Constance
    Mantes, Brigitte
    Izopet, Jacques
    Charpentier, Charlotte
    Wirden, Marc
    Maillard, Anne
    Morand-Joubert, Laurence
    Pallier, Coralie
    Plantier, Jean-Christophe
    Guinard, Jerome
    Tamalet, Catherine
    Cottalorda, Jacqueline
    Marcelin, Anne-Genevieve
    Desbois, Delphine
    Henqueii, Cecile
    Calvez, Vincent
    Brun-Vezinet, Francoise
    Masquelier, Bernard
    Costagliola, Dominique
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (11) : 2626 - 2631